Stephen Overstreet, MD
Gastroenterology · Louisville, KYNPI 1811995624
Payments from drug & device makers
Across 620 payments — averaging $15.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Johnson & Johnson$965
- Phathom Pharmaceuticals, Inc.$838
- Takeda Pharmaceuticals U.S.A., Inc.$721
- Sanofi$363
- plus $2K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 185 | $2,875 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 112 | $1,478 |
| Johnson & Johnson(2 entities) | 57 | $965 |
| Phathom Pharmaceuticals, Inc. | 83 | $838 |
| Takeda Pharmaceuticals U.S.A., Inc. | 43 | $721 |
| Sanofi | 19 | $363 |
| QOL Medical, LLC | 23 | $336 |
| Intercept Pharmaceuticals, Inc. | 14 | $277 |
| Regeneron Healthcare Solutions, Inc. | 11 | $229 |
| Bristol Myers Squibb | 9 | $185 |
| Ardelyx, Inc. | 9 | $174 |
| Madrigal Pharmaceuticals | 9 | $160 |
| Ironwood Pharmaceuticals, Inc | 9 | $159 |
| Pfizer | 7 | $104 |
| Lilly USA, LLC | 5 | $79 |
| Sandoz | 3 | $55 |
| Celltrion USA Inc. | 3 | $55 |
| Ipsen Biopharmaceuticals, Inc | 3 | $52 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Albireo Pharma, Inc. | 2 | $39 |
| Aimmune Therapeutics, Inc. | 1 | $33 |
| Merck | 2 | $32 |
| Gilead | 1 | $22 |
| Redhill Biopharma Inc. | 1 | $19 |
| Lucid Diagnostics Inc. | 1 | $18 |
| Innocoll Pharmaceuticals Limited | 1 | $15 |
| Shionogi Inc | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Braintree Laboratories, Inc. | 1 | $14 |
| Organon | 1 | $12 |
| Medtronic | 1 | $11 |
How this compares
$9,396 in reported general payments places this provider in the 75th percentile of 207 gastroenterology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Louisville
- Gerald DrydenLouisville$3.5M
- Matthew CaveLouisville$916K
- Michael KreaseLouisville$694K
- Thomas AbellLouisville$375K
- Sunana SohiLouisville$220K
- Jeffrey TuvlinLouisville$202K
- Loretta JophlinLouisville$174K
- Stephen McClaveLouisville$124K
- Ashutosh BarveLouisville$118K
- Nanlong LiuLouisville$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.